Needle-Free Inhalable Ebola Vaccine Useful in Remote Areas Devoid of Medical Personnel
A non-injectable vaccine showed positive results when tested on monkeys. It's easy to administer and also helps avoid the problem of needle disposal.
A non-injectable vaccine showed positive results when tested on monkeys. It's easy to administer and also helps avoid the problem of needle disposal.
NewLink, which focuses on developing therapies to fight cancer, has licensed research, development and manufacturing of the vaccine to Merck & Co., a much larger pharmaceutical company.
Last week, NewLink received an additional $8.1 million from a separate federal agency to support its vaccine research. The Public Health Agency of Canada first developed the Ebola vaccine before licensing it to a NewLink subsidiary.
India-Based Ella Foundation Successfully Completes Preliminary Studies on Ebola Vaccine
Animal experiments have been successful and the foundation claims that the vaccine is just a few steps away from entering clinical trials for human testing.
Animal experiments have been successful and the foundation claims that the vaccine is just a few steps away from entering clinical trials for human testing.
Clinical Trials for Two Ebola Vaccines Show No Adverse Reactions in Monkeys
There are other vaccines against Ebola that are already in human trials but they have reported side effects including fever and muscle and joint pain.
There are other vaccines against Ebola that are already in human trials but they have reported side effects including fever and muscle and joint pain.
Experimental Ebola Vaccine Found Safe at Early-Stage Human Trial
The most common side effects among volunteers were injection site pain and transient fever that appeared and resolved within 12 to 36 hours after vaccination.
The most common side effects among volunteers were injection site pain and transient fever that appeared and resolved within 12 to 36 hours after vaccination.
